A Comprehensive Overview of Epidemiology, Pathogenesis and the Management of Herpes Labialis
- PMID: 36680265
- PMCID: PMC9867007
- DOI: 10.3390/v15010225
A Comprehensive Overview of Epidemiology, Pathogenesis and the Management of Herpes Labialis
Abstract
Herpes labialis remains exceedingly prevalent and is one of the most common human viral infections throughout the world. Recurrent herpes labialis evolves from the initial viral infection by herpes simplex virus type 1 (HSV-1) which subsequently presents with or without symptoms. Reactivation of this virus is triggered by psychosocial factors such as stress, febrile environment, ultraviolet light susceptibility, or specific dietary inadequacy. This virus infection is also characterized by uninterrupted transitions between chronic-latent and acute-recurrent phases, allowing the virus to opportunistically avoid immunity and warrant the transmission to other vulnerable hosts simultaneously. This review comprehensively evaluates the current evidence on epidemiology, pathogenesis, transmission modes, clinical manifestations, and current management options of herpes labialis infections.
Keywords: antiviral agents; herpes labialis; management; prevention; treatments.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Human herpes simplex labialis.Clin Exp Dermatol. 2007 Nov;32(6):625-30. doi: 10.1111/j.1365-2230.2007.02473.x. Clin Exp Dermatol. 2007. PMID: 17953630 Review.
-
Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis.J Clin Virol. 2006 Dec;37(4):248-51. doi: 10.1016/j.jcv.2006.09.006. J Clin Virol. 2006. PMID: 17046320 Clinical Trial.
-
Herpes simplex virus infection: part I--Biology, clinical presentation and latency.Refuat Hapeh Vehashinayim (1993). 2005 Jan;22(1):7-15, 84. Refuat Hapeh Vehashinayim (1993). 2005. PMID: 15786655
-
Calcium spirulan derived from Spirulina platensis inhibits herpes simplex virus 1 attachment to human keratinocytes and protects against herpes labialis.J Allergy Clin Immunol. 2016 Jan;137(1):197-203.e3. doi: 10.1016/j.jaci.2015.07.027. Epub 2015 Sep 2. J Allergy Clin Immunol. 2016. PMID: 26341274
-
Herpes simplex viruses 1 and 2.Dermatol Clin. 2002 Apr;20(2):249-66. doi: 10.1016/s0733-8635(01)00003-1. Dermatol Clin. 2002. PMID: 12120439 Review.
Cited by
-
Atypical Clinical Manifestations of Herpes Simplex Virus-1 Infection.Int Med Case Rep J. 2024 Nov 7;17:933-937. doi: 10.2147/IMCRJ.S475249. eCollection 2024. Int Med Case Rep J. 2024. PMID: 39529697 Free PMC article.
-
An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application.Virulence. 2024 Dec;15(1):2425744. doi: 10.1080/21505594.2024.2425744. Epub 2024 Nov 13. Virulence. 2024. PMID: 39508503 Free PMC article. Review.
-
Therapeutic effects of acyclovir and acyclovir-clobetasol nanofibers vs. cream formulation for recurrent herpes labialis.BMC Oral Health. 2024 Nov 6;24(1):1348. doi: 10.1186/s12903-024-04948-6. BMC Oral Health. 2024. PMID: 39506756 Free PMC article. Clinical Trial.
-
Protective Mechanisms of Vaginal Lactobacilli against Sexually Transmitted Viral Infections.Int J Mol Sci. 2024 Aug 23;25(17):9168. doi: 10.3390/ijms25179168. Int J Mol Sci. 2024. PMID: 39273118 Free PMC article. Review.
-
A review of HSV pathogenesis, vaccine development, and advanced applications.Mol Biomed. 2024 Aug 29;5(1):35. doi: 10.1186/s43556-024-00199-7. Mol Biomed. 2024. PMID: 39207577 Free PMC article. Review.
References
-
- Herpes & Shingles: Symptoms & Treatments—Life Extension. [(accessed on 19 September 2021)]. Available online: https://www.lifeextension.com/protocols/infections/herpes-and-shingles.
-
- Billions Worldwide Living with Herpes. [(accessed on 9 May 2022)]. Available online: https://www.who.int/news/item/01-05-2020-billions-worldwide-living-with-....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
